BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 28745689)

  • 1. [Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis].
    Bulanov NM; Serova AG; Kuznetsova EI; Bulanova ML; Novikov PI; Kozlovskaya LV; Moiseev SV
    Ter Arkh; 2017; 89(6):48-55. PubMed ID: 28745689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
    Lieberthal JG; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; Seo P; Specks U; Ytterberg SR; Merkel PA; Monach PA;
    J Rheumatol; 2013 May; 40(5):674-83. PubMed ID: 23547217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?
    de Souza AW; Abdulahad WH; Sosicka P; Bijzet J; Limburg PC; Stegeman CA; Bijl M; Westra J; Kallenberg CG
    Clin Exp Immunol; 2014 Nov; 178(2):270-8. PubMed ID: 25052363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Moran SM; Monach PA; Zgaga L; Cuthbertson D; Carette S; Khalidi NA; Koening CL; Langford CA; McAlear CA; Moreland L; Pagnoux C; Seo P; Specks U; Sreih A; Wyse J; Ytterberg SR; Merkel PA; Little MA;
    Nephrol Dial Transplant; 2020 Feb; 35(2):283-291. PubMed ID: 30380100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis.
    Zhang Y; Shi W; Tang S; Li J; Yin S; Gao X; Wang L; Zou L; Zhao J; Huang Y; Shan L; Gounni AS; Wu Y; Yuan F; Zhang J
    Arthritis Res Ther; 2013 Oct; 15(5):R161. PubMed ID: 24286516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.
    Gou SJ; Yuan J; Wang C; Zhao MH; Chen M
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1884-91. PubMed ID: 24115193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.
    Shah S; Havill J; Rahman MH; Geetha D
    Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary angiotensinogen: an indicator of active antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    Wu L; Yang M; Feng X; Jin L; Wu C; Cui S; Zhou Z; Zhong X; Shi M; Yang Z; Cao W
    Nephrol Dial Transplant; 2019 May; 34(5):838-847. PubMed ID: 29733413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis.
    Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological analysis of ANCA-associated glomerulonephritis focusing on plasma cell infiltrate.
    Masuzawa N; Nishimura A; Mihara Y; Tamagaki K; Konishi E
    Clin Exp Nephrol; 2019 Dec; 23(12):1373-1381. PubMed ID: 31485791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis.
    Maruyama H; Hirayama K; Nagai M; Ebihara I; Shimohata H; Kobayashi M
    Clin Rheumatol; 2016 Oct; 35(10):2469-76. PubMed ID: 27251675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?
    Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M
    Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein-1 Can Predict Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Pilot Monocentric Study.
    Ahn SS; Kim JO; Yoon T; Song JJ; Park YB; Lee SW; Park SG
    Biomed Res Int; 2019; 2019():7508240. PubMed ID: 31236412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Geetha D; Sethi S; De Vriese AS; Specks U; Kallenberg CGM; Lim N; Spiera R; St Clair EW; Merkel PA; Seo P; Monach PA; Lepori N; Fessler BJ; Langford CA; Hoffman GS; Sharma R; Stone JH; Fervenza FC;
    Am J Nephrol; 2017; 46(3):231-238. PubMed ID: 28881339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of the determination of urinary excretion of kidney injury molecule-1 (KIM-1) in the assessment of the activity and prognosis of chronic glomerulonephritis].
    Brovko MY; Pulin AA; Kustova TY; Sholomova VI; Loshkareva OA; Taranova MV; Kozlovskaya LV
    Ter Arkh; 2016; 88(6):51-57. PubMed ID: 27296262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis.
    Rhee RL; Davis JC; Ding L; Fervenza FC; Hoffman GS; Kallenberg CGM; Langford CA; McCune WJ; Monach PA; Seo P; Spiera R; St Clair EW; Specks U; Stone JH; Merkel PA
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):251-257. PubMed ID: 29371340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
    Tam FW; Sanders JS; George A; Hammad T; Miller C; Dougan T; Cook HT; Kallenberg CG; Gaskin G; Levy JB; Pusey CD
    Nephrol Dial Transplant; 2004 Nov; 19(11):2761-8. PubMed ID: 15353578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary and serum soluble CD25 complements urinary soluble CD163 to detect active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis: a cohort study.
    Dekkema GJ; Abdulahad WH; Bijma T; Moran SM; Ryan L; Little MA; Stegeman CA; Heeringa P; Sanders JF
    Nephrol Dial Transplant; 2019 Feb; 34(2):234-242. PubMed ID: 29506265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies.
    Mosakowska M; Kania DB; Szamotulska K; Rymarz A; Niemczyk S
    BMC Nephrol; 2021 Aug; 22(1):290. PubMed ID: 34445984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.